Vacuna RSS
Princess of Asturias Award 2021 for the creators of Covid-19 vaccines
In its 2021 edition, the jury of the Princess of Asturias Award for Scientific and Technical Research wanted to recognize the work of several scientists considered as "protagonists of one of the most outstanding events in the history of science"
Novavax, the recombinant nanoparticle Covid-19 vaccine.
Novavax is a new recombinant nanoparticle vaccine of coronavirus 2 (SARS-CoV-2) with an adjuvant, based on saponins extracted from the bark of Quillaja saponaria Molina that improves immune responses and allows for a reduction in the vaccine dose.
Tags
- All
- ADN
- Alternativa
- Anticuerpo monoclonal
- Anticuerpos
- ARN
- beneficios
- Biorreactores
- Cambios sociales
- Células plas
- Células plasmáticas
- Coronavirus
- covid
- COVID-19
- Educación
- espíritu
- Genes
- Genoma humano
- health
- healthcare
- Hongo negro
- Inmunidad
- Médula ósea
- Método CRISPR/Cas9
- Mucorales
- Mucormicosis
- Mujeres Premio Nobel
- Nanopartículas
- Nicotiana benthamiana
- Nuevas profesiones
- Pandemia
- Premio Princesa de Asturias
- Quillaja saponaria
- Replicación
- Resiliencia
- Ribosomas
- Salud
- SARS-CoV-2
- School
- Tecnologías
- Telemedicina
- Trabajo en casa
- Vacuna
- Vacuna de origen vegetal
- virus
- Zoonosis